Tag: RDY

  • Stocks Upgrades: Facebook Inc. (NASDAQ:FB), The Boeing Company (NYSE:BA), Cell Therapeutics (NASDAQ:CTIC), Hi-Crush Partners (NYSE:HCLP), Nabors Industries (NYSE:NBR), Dr. Reddy’s Laboratories (NYSE:RDY)

    Facebook Inc. (NASDAQ:FB) upgraded to Overweight from Equal Weight at Evercore. Facebook Inc. (NASDAQ:FB) net profit margin is 21.40% and weekly performance is 4.49%. On last trading day company shares ended up $60.52. Analysts mean target price for the company is $77.76. Facebook Inc. (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is -0.98%.

    The Boeing Company (NYSE:BA) upgraded to Buy from Hold at Drexel Hamilton. The Boeing Company (NYSE:BA) shares advanced 0.67% in last trading session and ended the day on $131.84. BA gross Margin is 15.20% and its return on assets is 4.80%.The Boeing Company (NYSE:BA) quarterly performance is 3.36%.

    Cell Therapeutics Inc. (NASDAQ:CTIC) initiated with a Buy at Ladenburg Thalmann. Cell Therapeutics Inc. (NASDAQ:CTIC) shares moved up 12.99% in last trading session and was closed at $2.87, while trading in range of $2.65 – $3.00. Cell Therapeutics Inc. (NASDAQ:CTIC) year to date (YTD) performance is 50.26%.

    Hi-Crush Partners LP (NYSE:HCLP) initiated with a Outperform at Cowen. Hi-Crush Partners LP (NYSE:HCLP) ended the last trading day at $47.89. Company weekly volatility is calculated as 2.97% and price to cash ratio as 214.40.Hi-Crush Partners LP (NYSE:HCLP) showed a positive weekly performance of 6.37%.

    Nabors Industries Ltd. (NYSE:NBR) upgraded to Buy from Hold at Jefferies. Nabors Industries Ltd. (NYSE:NBR) net profit margin is 3.00% and weekly performance is 4.80%. On last trading day company shares ended up $26.00. Analysts mean target price for the company is $27.09. Nabors Industries Ltd. (NYSE:NBR) distance from 50-day simple moving average (SMA50) is 6.20%.

    Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) upgraded to Overweight from Equal Weight at Barclays. Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) net profit margin is 24.00% and weekly performance is -4.56%. On last trading day company shares ended up $38.90. Analysts mean target price for the company is $48.75. Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) distance from 50-day simple moving average (SMA50) is -11.05%.